Search

Stradling

Biomerica Enters Into $7 Million At Market Issuance Sales Agreement

Biomerica Inc.

Represented Biomerica Inc. (NASDAQ: BMRA) in connection with an At Market Issuance Sales Agreement with B. Riley FBR, Inc., in connection with the offering, issuance and sale of up to an aggregate of $7 million of shares of its Common Stock under its previously-filed shelf registration statement on Form S-3 for the offering of up to $45 million of its Common Stock.

Biomerica is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care and in hospital/clinical laboratories for the early detection of medical conditions and diseases.

The Newport Beach-based deal team representing Biomerica included Chris IveyJason Lee and Matthew Brodsky.